Series A - Kernal Biologics

Series A - Kernal Biologics

Investment Firm

Overview

Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.

Announced Date

Jul 07, 2022

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Hummingbird Ventures

Hummingbird Ventures

Hummingbird Ventures is a early_stage_venture and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorAmino Collective
Participant InvestorAmgen Ventures
Participant InvestorHBM Genomics
Participant InvestorHummingbird Ventures

Round Details and Background

Kernal Biologics raised $25000000 on 2022-07-07 in Series A

Kernalbio creates mRNA therapies that instruct specific cells on how to make their own medicine.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 17, 2020
Venture Round - Kernal Biologics
-undefined
May 23, 2018
Non Equity Assistance - Kernal Biologics
1-undefined
Oct 21, 2020
Seed Round - Kernal Biologics
3-undefined
Jul 07, 2022
Series A - Kernal Biologics
5-25.0M

Recent Activity

There is no recent news or activity for this profile.